- Location
Astrazeneca
"-
Astrazeneca Unveils $224m Production and Packaging Plant in Russia
Oct 23, 2015Pharmaceutical and biologics company AstraZeneca has unveiled a new $224m worth production and packaging plant in Kaluga, Russia. The investment is said to be the largest foreign investment in the construction of a new pharmaceutical ...
Tags: Astrazeneca, Packaging, medicines
-
Seren Photonics Was Awarded Third Place in The 'materials' Category
Jul 15, 2015As one of 30 finalists at the UK Royal Society of Chemistry's Emerging Technologies Competition 2015 in London on 29 June, Seren Photonics Ltd of Pencoed Technology Park, UK was awarded third place in the 'Materials' category for its ...
Tags: Seren's technology, LED
-
Hutchison China Meditech Had Enrolled Patients for a Study of Colorectal Cancer
Sep 11, 2014Amid daily updates from the pharmaceuticals industry on the latest clinical trials, last week's announcement by Hutchison China MediTech that it had enrolled patients for a study of colorectal cancer was hardly cause for excitement. But ...
Tags: Health, Medicine, Chinese Pharma
-
The Grants Are Being Awarded to Organizations Nationwide
Feb 26, 2014The AstraZeneca HealthCare Foundation's Connections for Cardiovascular HealthSM program today announced it will award nearly $3.7 million in grants to 19 nonprofit organizations dedicated to improving cardiovascular health in local ...
Tags: Astrazeneca, Healthcare Foundation, Cardiovascular Health, heart health
-
U.S. Food and Drug Administration Will Investigate Possible Links
Feb 25, 2014TUESDAY Feb. 11, 2014, 2014 -- The U.S. Food and Drug Administration announced Tuesday that it will investigate possible links between the diabetes drug saxagliptin and a heightened risk for heart failure among users. In a statement, the ...
Tags: FDA, Diabetes Drug, Heart Failure, NEJM
-
AstraZeneca,DKFZ and EORTC Have Joined The Consortium.WIN Is a Unique Global Network
Feb 11, 2014The Worldwide Innovative Network(WIN)Consortium in personalized cancer medicine is proud to announce that AstraZeneca,DKFZ and EORTC have joined the Consortium.WIN is a unique global network of leading academics,industries,payors and ...
Tags: WIN, cancer medicine, DKFZ, EORTC
-
FOB Synthesis and AstraZeneca Have Entered Into a Research and Development Option
Feb 7, 2014US-based FOB Synthesis and AstraZeneca have entered into a research and development option and license agreement for the development of a novel antibiotic for the treatment of drug-resistant bacterial infections. The new antibiotics will ...
Tags: FOB, BLI, AstraZeneca
-
Diabetes Alliance Is Providing a Three-Year Grant to The American Diabetes Pathway
Jan 16, 2014AstraZeneca (NYSE:AZN) and Bristol-Myers Squibb Company (NYSE:BMY) today announced that the companies' U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association's Pathway to Stop Diabetes program. The ...
-
Farxiga Has Been Approved to Treat Adults with Type 2 Diabetes
Jan 13, 2014Farxiga (dapaglifozin) has been approved by the U.S. Food and Drug Administration to treat adults with type 2 diabetes, the agency said Wednesday in a news release. The drug, to be used for blood sugar control along with proper diet and ...
Tags: Farxiga, Type 2 Diabetes, Medicine News
-
Here Are Some of The Latest Health and Medical News Developments
Jan 10, 2014Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Officials Confirm First North American Death From H5N1 Bird Flu The first death in North America from H5N1 bird flu has been ...
Tags: Health Highlights, Health
-
Immunocore Entered Into an Oncology Collaboration and Licensing Agreement with MedImmune
Jan 9, 2014Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, today announced that it has entered into an oncology research collaboration and licensing agreement with ...
Tags: Immunocore, oncology research, collaboration and licensing agreement
-
The Drug Arimidex Reduces Risk of Developing Breast Cancer at High Risk for The Disease
Dec 26, 2013The drug Arimidex reduces the risk of developing breast cancer by more than 50 percent among postmenopausal women at high risk for the disease, according to a new study. The finding, scheduled for presentation Thursday at the San Antonio ...
Tags: Arimidex, breast cancer, postmenopausal women, women health, anastrozole
-
BioWa and Lonza Have Entered Into a Licensing Agreement with MedImmune
Dec 13, 2013BioWa, a wholly owned subsidiary of Kyowa Hakko Kirin, and Lonza, a biotechnology company, have entered into a licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca. MedImmune has licensed ...
-
The European Commission Has Granted Marketing Authorisation
Dec 10, 2013The European Commission (EC) has granted marketing authorisation for AstraZeneca's new four-in-one influenza vaccine Fluenz Tetra for the prevention of influenza in children and adolescents from 24 months up to 18 years of age. The ...
Tags: Chronic Hepatitis, Medicine
-
EMA Has Issued Positive Opinion
Nov 26, 2013European Medicines Agency's (EMA) the Committee for Medicinal Products for Human Use (CHMP) has issued positive opinion for AstraZeneca and Bristol-Myers Squibb's of Xigduo for adults aged 18 and older with type 2 diabetes mellitus. The ...
